Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GH NYSE:HIMS NASDAQ:OPCH NASDAQ:SGRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$46.25+1.3%$46.48$20.14▼$53.42$5.65B1.442.18 million shs2.08 million shsHIMSHims & Hers Health$49.93+4.9%$53.82$13.47▼$72.98$11.19B2.0224.19 million shs23.98 million shsOPCHOption Care Health$29.78+2.1%$31.58$21.39▼$35.53$4.78B0.731.82 million shs1.51 million shsSGRYSurgery Partners$22.06-1.3%$22.41$18.87▼$33.97$2.87B1.91.20 million shs1.80 million shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health+1.34%-3.83%-5.88%+1.14%+44.53%HIMSHims & Hers Health+4.75%-1.02%-22.56%+86.64%+145.46%OPCHOption Care Health+2.09%-3.12%-5.55%-7.35%-4.37%SGRYSurgery Partners-1.34%+1.01%+14.30%+4.01%-21.72%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health4.3995 of 5 stars3.53.00.04.42.52.50.6HIMSHims & Hers Health2.5272 of 5 stars2.02.00.00.03.03.31.9OPCHOption Care Health4.5198 of 5 stars2.45.00.04.33.21.71.9SGRYSurgery Partners2.8493 of 5 stars3.41.00.00.03.00.02.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.05Buy$54.4517.73% UpsideHIMSHims & Hers Health 1.92Reduce$39.83-20.22% DownsideOPCHOption Care Health 2.88Moderate Buy$35.5019.21% UpsideSGRYSurgery Partners 2.70Moderate Buy$33.5652.11% UpsideCurrent Analyst Ratings BreakdownLatest SGRY, HIMS, GH, and OPCH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$45.00 ➝ $48.007/14/2025GHGuardant HealthEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/10/2025OPCHOption Care HealthBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$38.006/24/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$45.006/23/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell6/23/2025HIMSHims & Hers HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$30.006/23/2025HIMSHims & Hers HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderperform ➝ Underperform6/23/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold6/18/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$36.006/13/2025GHGuardant HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$60.00 ➝ $65.006/11/2025HIMSHims & Hers HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Equal Weight$40.00(Data available from 7/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$739.02M7.75N/AN/A($1.13) per share-40.93HIMSHims & Hers Health$1.78B6.26$0.37 per share135.16$2.16 per share23.11OPCHOption Care Health$5.19B0.94$1.68 per share17.73$8.25 per share3.61SGRYSurgery Partners$3.11B0.91$1.85 per share11.94$25.15 per share0.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$436.37M-$3.39N/AN/AN/A-53.82%N/A-26.77%7/30/2025 (Estimated)HIMSHims & Hers Health$126.04M$0.6972.3696.011.769.24%22.75%15.51%8/4/2025 (Estimated)OPCHOption Care Health$211.82M$1.2424.0223.631.894.12%16.90%7.00%7/30/2025 (Estimated)SGRYSurgery Partners-$168.10M-$1.53N/A27.23N/A-6.10%2.41%0.99%8/5/2025 (Estimated)Latest SGRY, HIMS, GH, and OPCH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025SGRYSurgery Partners$0.16N/AN/AN/A$816.96 millionN/A8/4/2025Q2 2025HIMSHims & Hers Health$0.17N/AN/AN/A$550.06 millionN/A7/30/2025Q2 2025GHGuardant Health-$0.52N/AN/AN/A$211.19 millionN/A7/30/2025Q2 2025OPCHOption Care Health$0.40N/AN/AN/A$1.35 billionN/A5/12/2025Q1 2025SGRYSurgery Partners$0.08$0.04-$0.04-$0.30$777.77 million$776.00 million5/5/2025Q1 2025HIMSHims & Hers Health$0.12$0.20+$0.08$0.20$535.21 million$586.01 million4/30/2025Q1 2025GHGuardant Health-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ASGRYSurgery PartnersN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A4.113.76HIMSHims & Hers HealthN/A1.591.32OPCHOption Care Health0.821.541.02SGRYSurgery Partners1.091.891.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%HIMSHims & Hers Health63.52%OPCHOption Care Health98.05%SGRYSurgery PartnersN/AInsider OwnershipCompanyInsider OwnershipGHGuardant Health6.10%HIMSHims & Hers Health17.71%OPCHOption Care Health0.64%SGRYSurgery Partners2.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health2,021123.89 million116.33 millionNot OptionableHIMSHims & Hers Health1,637223.83 million184.19 millionOptionableOPCHOption Care Health8,088163.75 million162.70 millionOptionableSGRYSurgery Partners15,000128.16 million125.21 millionOptionableSGRY, HIMS, GH, and OPCH HeadlinesRecent News About These CompaniesVictory Capital Management Inc. Sells 371,195 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)July 23 at 4:12 AM | marketbeat.comSegall Bryant & Hamill LLC Has $3.53 Million Stake in Surgery Partners, Inc. (NASDAQ:SGRY)July 19, 2025 | marketbeat.comSurgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call ...July 18, 2025 | gurufocus.comSurgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call ...July 18, 2025 | gurufocus.comSurgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call DetailsJuly 18, 2025 | globenewswire.com18,817 Shares in Surgery Partners, Inc. (NASDAQ:SGRY) Bought by Teacher Retirement System of TexasJuly 18, 2025 | marketbeat.comWhy Surgery Partners (SGRY) Stock Is Trading Up TodayJuly 16, 2025 | msn.comSurgery Partners, Inc. (SGRY): A Bull Case TheoryJuly 15, 2025 | msn.com1 Healthcare Stock to Keep an Eye On and 2 to Be Wary OfJuly 7, 2025 | finance.yahoo.comCIBRA Capital Ltd Makes New Investment in Surgery Partners, Inc. (NASDAQ:SGRY)July 2, 2025 | marketbeat.comSurgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Rating of "Moderate Buy" by BrokeragesJuly 2, 2025 | marketbeat.comSGRY Surgery Partners, Inc. - Seeking AlphaJune 27, 2025 | seekingalpha.comSurgery Partners says no to Bain — here’s the bigger pictureJune 24, 2025 | beckersasc.comBRSI Alert: Surgery Partners (SGRY) Now OversoldJune 19, 2025 | nasdaq.comSurgery Partners: The Plunge Doesn't Justify An UpgradeJune 18, 2025 | seekingalpha.comSurgery Partners stock falls after concluding discussions with Bain CapitalJune 18, 2025 | investing.comSurgery Partners rejects Bain Capital's acquisition offer, opts to remain publicJune 18, 2025 | bizjournals.comSurgery Partners declines Bain Capital bid, stays publicly listed companyJune 18, 2025 | msn.comSURGERY PARTNERS, INC. and Bain Capital Conclude DiscussionsJune 18, 2025 | finance.yahoo.comStock Movers: JetBlue, Solar Sector, Surgery PartnersJune 18, 2025 | bloomberg.comSurgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private ProposalJune 18, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 AI Infrastructure Stocks With Strong Growth, Not HypeBy Chris Markoch | June 26, 2025View 3 AI Infrastructure Stocks With Strong Growth, Not HypeWhy Wall Street Is Betting on These 3 Comeback StocksBy Nathan Reiff | July 12, 2025View Why Wall Street Is Betting on These 3 Comeback Stocks3 Stocks With Near-Unanimous Buys That Could Rally HigherBy Nathan Reiff | July 2, 2025View 3 Stocks With Near-Unanimous Buys That Could Rally HigherThese 3 Rare Earth Stocks Are Surging Alongside MP MaterialsBy Leo Miller | July 19, 2025View These 3 Rare Earth Stocks Are Surging Alongside MP MaterialsSGRY, HIMS, GH, and OPCH Company DescriptionsGuardant Health NASDAQ:GH$46.25 +0.61 (+1.34%) Closing price 07/22/2025 04:00 PM EasternExtended Trading$46.90 +0.65 (+1.40%) As of 08:52 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$49.93 +2.33 (+4.89%) Closing price 07/22/2025 03:58 PM EasternExtended Trading$50.01 +0.09 (+0.18%) As of 09:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Option Care Health NASDAQ:OPCH$29.78 +0.61 (+2.09%) Closing price 07/22/2025 04:00 PM EasternExtended Trading$30.20 +0.41 (+1.39%) As of 08:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.Surgery Partners NASDAQ:SGRY$22.06 -0.30 (-1.34%) Closing price 07/22/2025 04:00 PM EasternExtended Trading$22.58 +0.52 (+2.33%) As of 08:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Meta’s AI Titan Clusters Are a Game-Changer for Broadcom Block Levels Up: What S&P 500 Inclusion Means for Investors Steel Dynamics Stock Steady on Long-Term Prospects Amazon Stock Rally Hits New Highs: Buy Into Earnings? A Bullish Storm Is Brewing for High-Yield Verizon’s Share Price Forget the Hype—TSMC Is the AI Stock That Actually Delivers Rigetti Soars 30% on Latest Quantum Leap: What It Means Long-Term Domino’s Delivers Another Discounted Entry for Income Investors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
